11. 1. Full IC no. / RN
2. Age (specify units i.e days, months, years)
3. Allergy status (not including current allergy in the report)
4. Weight (paediatric / chemotherapy patient)
11
1. PATIENT INFORMATION
13. INITIAL REPORT
First submission of report to NPRA about a particular patient
involving a particular ADR
13
INITIAL / FOLLOW-UP REPORT
14. FOLLOW-UP REPORT
Submission of further reports related to the same case to
inform of additional information not mention previously or
which occurred after the initial report - changes of diagnosis,
additional reactions, changes of outcome of reaction etc.
Mention the initial PhIS no. / online submission report
14
INITIAL / FOLLOW-UP REPORT
15. Tell the story
Signs & symptoms, final diagnosis
Include detailed relevant information e.g. brand switching,
rechallenge etc.
15
3. ADR DESCRIPTION
18. Time interval between 1st dose (initiation) of the drug
until 1st sign of the ADR e.g
Immediately
30 minutes
1 hour
2 days
3 weeks
4 months
18
4. TIME TO ONSET
19. Do not submit old ADR cases
Submit only ADR cases that happened in the current
year or the year before, except if the reaction still on-
going until now
State exact date of reaction e.g 17/10/2020
19
5. DATE OF REACTION
20. Dechallenge
stop drug/ reduce dose
record the outcome (ADR improved or not improved)
Rechallenge
giving one drug again under the same conditions as before
skip at least one dosing interval (ADR must resolved at the
time of rechallenge)
record the outcome (recurrence or no recurrence of ADR)20
6. DECHALLENGE & RECHALLEGE
21. Reaction subsided after stopping drug/ reducing dose?
‘YES’
Positive dechallenge
Stop medication/reduce dose & reaction improving / improved
‘NO’
Negative dechallenge
Stop medication/reduce dose but reaction worsen / no improvement
‘UNKNOWN’
Unknown if the drug withdrawn or not (no information regarding dechallenge)
Unknown reaction outcome either positive or negative dechallenge
‘N/A’
If medication still continued 21
DECHALLENGE
22. Reaction reappeared after reintroducing drug?
‘YES’
Positive rechallenge
Reintroduced drug & reaction reappear
‘NO’
Negative rechallenge
Reintroduced drug but reaction did not appear
‘UNKNOWN’
Rechallenge done but do not know of the outcome
‘N/A’
No rechallenge done / no information on rechallenge
22
RECHALLENGE
24. Severity is a point of intensity of the ADR:
24
SEVERITY
25. ADR that may result in the following outcomes:
Death
Life-threatening
Requires/prolongs hospitalization
Disability/incapacity
Congenital anomaly
N/A (not serious) 25
SERIOUSNESS
26. Condition of patient at time of reporting
Recovered
Recovering
Not recovered
Unknown
Fatal- date and cause of death
26
9. OUTCOME
27. Use WHO assessment scale
Certain (C1)
Probable (C2)
Possible (C3)
Unlikely (C4)
Unclassifiable (C5)
27
10. DRUG-REACTION RELATIONSHIP
29. Product brand name / generic name
Dose & frequency given
MAL and batch no.
Therapy start date/ therapy stop date
Indication
29
11. SUSPECTED DRUG
30. Relevant information e.g.:
If ADR is hypokalaemia/ hypoglycaemia:
Lab data: serum K+ or blood glucose
If ADR is fever:
Lab data: temperature, WBC
Please note if none:
No temperature taken / no blood investigation done
30
12. RELEVANT INVESTIGATIONS /
LABORATORY DATA
31. No known drug allergy (NKDA)
History of allergy to….
No history / history of …. e.g. epilepsy
Underlying disease
History of taking suspected medication previously &
the outcome
Patient health status
31
RELEVANT MEDICAL HISTORY
32. Designation e.g. Specialist, MO, Pharmacist, PRP,
assistant pharmacist, Nurse, MA, Consumer
Email address
Tel no.
Date of report: do not compile old reports
32
13. REPORTER DETAILS
34. 34
You can make a difference
• Fill in the form completely and accurately
• Use the checklists
• Research e.g. VigiAccess, product leaflet
• Ask questions
• TELL OTHERS
35. 35
THANK YOU FOR YOUR
ATTENTION!
Any questions?
Contact me at:
nazmiliana@moh.gov.my
0179224977